Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
The Netherlands Journal of Medicine|September 22, 2009
Where the immune response meets the vessel wallR J Bisoendial, E S G Stroes, P P TakCurrent Pharmaceutical Design|January 14, 2011
Critical determinants of cardiovascular risk in rheumatoid arthritisR J Bisoendial, E S G Stroes, P P TakRheumatology (Oxford, England)|August 19, 2007
Systemic inflammation as a risk factor for atherothrombosisS I van Leuven, R Franssen, J J Kastelein, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 19, 2021
Working towards full eradication of lipid-driven cardiovascular risk?N S Nurmohamed, E S G StroesThe Netherlands Journal of Medicine|May 29, 2013
Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promisesJ Besseling, G K Hovingh, E S G StroesCurrent Pharmaceutical Design|January 16, 2013
The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular diseaseA E Bochem, J A Kuivenhoven, E S G StroesNederlands Tijdschrift Voor Geneeskunde|November 17, 2020
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]R M Hoogeveen, E S G Stroes, J H CornelDiabetes, Obesity & Metabolism|October 11, 2007
Normalization of metabolic syndrome using fenofibrate, metformin or their combinationM Nieuwdorp, E S G Stroes, J J P Kastelein, et al.Best Practice & Research. Clinical Rheumatology|May 19, 2001
Is early rheumatoid arthritis the same disease process as late rheumatoid arthritis?P P TakExpert Review of Cardiovascular Therapy|June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemiaN S Nurmohamed, G M Dallinga-Thie, E S G StroesPageof 22